Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF7 antisense RNA 2 (ARHGEF7-AS2)
- Target
- ARHGEF7-AS2
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
ARHGEF7 antisense RNA 2 (ARHGEF7-AS2) is a long non-coding RNA gene identified in gene databases such as NCBI Gene and Ensembl under accession numbers like 100874238 and ENSG00000235875[2]. It does not code for a protein and is classified as an lncRNA[5]. While some lncRNAs are known to play regulatory roles in development, disease, and cell biology, there is currently no specific biological function, disease role, or clinical significance described for ARHGEF7-AS2 itself in the available scientific literature or gene compendia. There are no known drug interactions, mechanisms of action, biomarker uses, or safety considerations for this non-coding RNA based on current knowledge[2][5][6]. Note: Do not confuse ARHGEF7-AS2 with ARHGEF7, which is a coding gene for Rho guanine nucleotide exchange factor 7 (beta-PIX), a protein involved in cellular signaling[1][3]. ARHGEF7-AS2 is a non-coding antisense transcript and should not be considered a protein-coding target.
- Other names
- ARHGEF7-AS2ARHGEF7 antisense RNA 2 (non-protein coding)
02
Mechanism of action
None reported
03
Biological functions
Other (lncRNA regulatory roles are possible, but specific molecular functions for ARHGEF7-AS2 have not been clearly described in current literature or databases)
04
Disease associations
Other (General association with lncRNAs and human diseases, particularly cancer, has been reported, but there is no specific documented disease association for ARHGEF7-AS2 in the current major gene/disease repositories or the literature retrieved)
Beyond the preview
Go deeper on ARHGEF7 antisense RNA 2 (ARHGEF7-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARHGEF7 antisense RNA 2 (ARHGEF7-AS2).